Try our Advanced Search for more refined results

July 12, 2022

Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al

Track this case

Case Number:

1:22-cv-00924

Court:

Delaware

Nature of Suit:

Patent

Judge:

Colm F. Connolly

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 12, 2022

    Pfizer, Moderna Face New IP Litigation Over COVID Vaccines

    Pfizer and Moderna on Tuesday were targeted in another round of patent suits by rival Alnylam Pharmaceuticals over their COVID-19 vaccines, months after Alnylam claimed the vaccines ripped off a different aspect of its "breakthrough" biotechnology in related litigation.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login